Why Is Micro Cap HeartBeam Stock Surging On Wednesday?

Benzinga_recent_news12-11

HeartBeam, Inc.’s (NASDAQ:BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro. On Wednesday, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590397875?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/10/Chest-Pain-Illness-Causing-Heart-Attack-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-12-11 00:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590397875","market":"sh","top_or_hot":-1,"title":"Why Is Micro Cap HeartBeam Stock Surging On Wednesday?","media":"Benzinga_recent_news","content":"<div>\n<p>HeartBeam, Inc.’s (NASDAQ:BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro.\nOn Wednesday, ...</p>\n\n<a href=\"https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is Micro Cap HeartBeam Stock Surging On Wednesday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is Micro Cap HeartBeam Stock Surging On Wednesday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-11 00:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>HeartBeam, Inc.’s (NASDAQ:BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro.\nOn Wednesday, ...</p>\n\n<a href=\"https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday","article_id":"2590397875","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/10/Chest-Pain-Illness-Causing-Heart-Attack-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/12/49310554/why-is-micro-cap-heartbeam-stock-surging-on-wednesday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2590397875","pubTimestamp":1765384020,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac detection technology.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","ECG":"Everus Construction Group, Inc.","BEAT":"Heartbeam Inc","BK4129":"建筑与工程"},"translate_title":"为什么Micro Cap HeartBeam股票周三飙升？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ECG":1,"BEAT":1},"content_text":"HeartBeam, Inc.’s (NASDAQ:BEAT) stock is trading higher on Monday, with a session volume of 193.38 million compared to the average volume of 2.191 million as per data from Benzinga Pro.\nOn Wednesday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for HeartBeam’s 12-lead electrocardiogram (ECG) synthesis software for the assessment of arrhythmias.\nArrhythmias are irregular heartbeats where the heart beats too fast (tachycardia), too slow (bradycardia), or with an erratic rhythm.\nThe clearance follows HeartBeam’s successful appeal of a prior Not Substantially Equivalent (NSE) determination.\nUnlike any single-lead or 6-lead consumer device, HeartBeam’s patented cable-free technology captures the heart’s electrical signals in three non-coplanar dimensions and synthesizes them into a 12-lead ECG representation.\nThis allows patients to obtain an ECG reading for their arrhythmia from the comfort of home, or wherever they happen to be.\nThe synthesized 12-lead ECG is promptly reviewed by an on-demand, board-certified cardiologist.\nThe FDA clearance positions the company to advance several growth initiatives:\nLimited Launch (Early 2026): The Company plans a targeted rollout to select concierge and preventive cardiology practices that have already expressed strong interest. This controlled introduction will validate real-world performance and establish reference sites ahead of broader commercialization.\nHeart Attack Detection Pathway: The Company will pursue an additional indication for heart attack detection, supported by promising proof-of-concept data. Management views this as a major expansion opportunity, potentially reaching tens of millions of U.S. patients.\nExtended-Wear 12-Lead Patch: The company is progressing its on-demand 12-lead ECG extended-wear patch, now at the working-prototype stage. The platform targets a multi-billion-dollar reimbursable market and has the potential to offer best-in-class capabilities.\nLongitudinal Data and AI: As adoption scales, the company aims to leverage the longitudinal, data-rich output of its 3D ECG technology. Continuous patient-generated 12-lead ECG records could enable AI-driven screening and predictive tools that exceed the capabilities of traditional wearables or single-timepoint ECGs.\nThe company plans to initiate a limited U.S. commercial launch in the first quarter of 2026 with select concierge and preventive cardiology practices that have already signaled strong adoption interest.\nPrice Action: BEAT stock is up 75.73% at $1.42 at the last check on Wednesday.\nRead Next:\nPhoto by Chinnapong via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590397875","isCrawlerRequest":true}